picibanil and Arteriovenous-Malformations

picibanil has been researched along with Arteriovenous-Malformations* in 3 studies

Other Studies

3 other study(ies) available for picibanil and Arteriovenous-Malformations

ArticleYear
Percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation.
    The British journal of oral & maxillofacial surgery, 2016, Volume: 54, Issue:2

    Congenital arteriovenous malformations (AVM) in the maxillofacial region are rare, but potentially life-threatening, vascular lesions. Here we review our experience of 13 patients with AVM of the facial soft tissues who were treated using percutaneous sclerotherapy with fibrin glue combined with OK-432 and bleomycin after embolisation. The mean (range) follow-up was 27 (14-58) months. Three of the lesions were completely controlled, eight were nearly completely controlled, and the other two were partly controlled. Our experience is that percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation is safe and effective.

    Topics: Arteriovenous Malformations; Bleomycin; Fibrin Tissue Adhesive; Humans; Picibanil; Sclerotherapy

2016
A multidisciplinary approach to treating maxillofacial arteriovenous malformations in children.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 108, Issue:1

    Congenital arteriovenous malformations (AVMs) in the maxillofacial region are rare, potentially life-threatening, vascular lesions. This study reviewed our experience with a multidisciplinary approach to treating maxillofacial AVMs in children.. Thirteen patients (10 boys and 3 girls) with AVMs involving the facial soft tissues or jaws were treated using a multidisciplinary approach that included: 1) superselective intra-arterial embolization (SIAE); 2) bone wax packing (BWP) of the bone cavity and curettage; and 3) compartmentalization and sclerotherapy.. The mean follow-up was 13.5 months, with a range of 6-22 months. The following outcomes were obtained: 9 lesions (69.2%) were completely involuted, 3 lesions (23.1%) were mostly involuted, and 1 lesion (7.7%) was partially involuted. The rates of completely and mostly involuted AVMs involving the jaws treated using SIAE, BWP, and curettage were 80% and 20%, respectively. The rates of completely, mostly, and partially involuted AVMs involving soft tissues treated by compartmentalization and sclerotherapy were 60%, 30%, and 10%, respectively.. SIAE was reliable for controlling bleeding and as adjunctive treatment for maxillofacial AVMs in children. SIAE followed by BWP of the bone cavity and curettage was a simple, safe, and effective method for treating AVMs of the jaws; SIAE followed by compartmentalization and the injection of OK-432 and pingyangmycin was a reliable alternative treatment for AVMs of the soft tissues in the maxillofacial region.

    Topics: Adolescent; Arteriovenous Malformations; Bleomycin; Bone Substitutes; Child; Child, Preschool; Combined Modality Therapy; Curettage; Drug Combinations; Embolization, Therapeutic; Face; Female; Follow-Up Studies; Hemostatics; Humans; Injections, Intra-Arterial; Male; Mandible; Maxilla; Mouth; Palmitates; Picibanil; Sclerosing Solutions; Sclerotherapy; Treatment Outcome; Waxes

2009
[Intralesional treatment of vascular lesions in the head-neck region].
    Ugeskrift for laeger, 2004, Feb-16, Volume: 166, Issue:8

    Topics: Antineoplastic Agents; Arteriovenous Malformations; Hemangioma; Humans; Injections, Intralesional; Laser Therapy; Picibanil

2004